Open AccessThree Years of Experience with an IgM-Enriched Human Intravenous Immunoglobulin-Based Treatment for Patients with Early Donor-Specific Anti-HLA Antibodies after Lung Transplantation
Author(s) -
F. Ius,
W. Sommer,
Murielle Verboom,
C. Erdfelder,
Christian Kühn,
M. Avşar,
T. Siemeni,
J. Salman,
D. Bobylev,
Michael Hallensleben,
Mark Greer,
Jens Gottlieb,
Nicolaus Schwerk,
Carsten Müller,
Axel Haverich,
I. Tudorache,
G. Warnecke
Publication year - 2017
Publication title -
the thoracic and cardiovascular surgeon
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.458
H-Index - 52
eISSN - 1439-1902
pISSN - 0171-6425
DOI - 10.1055/s-0037-1598772
Subject(s) - medicine , antibody , immunoadsorption , rituximab , intravenous immunoglobulins , lung transplantation , transplantation , intravenous immunoglobulin therapy , immunology , human leukocyte antigen , antigen